Intelligent Bio Solutions Inc.
Organization details
- Legal name
- Intelligent Bio Solutions Inc.
- Former names
- GBS Inc. Glucose Biosensor Systems (Greater China) Holdings, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- New York
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- June
- Ticker symbol
- INBS
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001725430
- EIN
- 82-1512711
Board of directors
-
Christopher Towers · DirectorSince 2023
-
Jason Isenberg · DirectorSince 2026
-
Jonathan Scott Hurd · DirectorSince 2026
-
Nicola Marion Fraser · DirectorSince 2024
-
Steven Constantine Boyages · DirectorSince 2026
Director election results
Annual meeting of October 16, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
72.9%
-
72.9%
-
92.0%
-
92.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 18, 2026 | Steven Constantine Boyages Director | Grant or award | +5,000 | — | — |
| Mar 18, 2026 | Nicola Marion Fraser Director | Grant or award | +5,000 | — | — |
| Mar 18, 2026 | Sakiris Spiro Kevin Officer (Chief Financial Officer) | Grant or award | +9,150 | — | — |
| Mar 18, 2026 | Jonathan Scott Hurd Director | Grant or award | +5,000 | — | — |
| Mar 18, 2026 | Jason Isenberg Director | Grant or award | +5,000 | — | — |
| Mar 18, 2026 | Simeonidis Harry Officer (Chief Executive Officer) | Grant or award | +9,150 | — | — |
| Mar 18, 2026 | Sakiris Spiro Kevin Officer (Chief Financial Officer) | Grant or award | +21,350 | — | — |
| Mar 18, 2026 | Simeonidis Harry Officer (Chief Executive Officer) | Grant or award | +21,350 | — | — |
| Sep 25, 2024 | Simeonidis Harry Officer (Chief Executive Officer) | Grant or award | +40,000 | — | — |
| Sep 25, 2024 | Sakiris Spiro Kevin Officer (Chief Financial Officer) | Grant or award | +34,500 | — | — |
| Mar 20, 2024 | Sakiris Spiro Kevin Officer (Chief Financial Officer) | In-the-money exercise | +9,394 | — | — |
| Oct 4, 2023 | Christopher Towers Director | Open-market purchase | +9,090 | — | — |
| Oct 4, 2023 | Sakiris Spiro Kevin Officer (Chief Financial Officer) | Open-market purchase | +112,727 | — | — |
| Sep 1, 2023 | Simeonidis Harry Officer (CEO) | Open-market purchase | +50 | $1.85 | $93 |
| Aug 31, 2023 | Simeonidis Harry Officer (CEO) | Open-market purchase | +100 | $1.92 | $192 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Intelligent Bio Solutions Inc.
How many directors are on Intelligent Bio Solutions Inc.'s board?
Intelligent Bio Solutions Inc.'s board has 5 directors: Christopher Towers, Jason Isenberg, Jonathan Scott Hurd, Nicola Marion Fraser and Steven Constantine Boyages.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="intelligent-bio-solutions-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.